Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2006-03-07
2006-03-07
Park, Hankyel T. (Department: 1648)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C424S184100, C424S201100, C424S202100, C424S203100, C424S212100, C424S217100, C424S218100
Reexamination Certificate
active
07008790
ABSTRACT:
A method of immunization, and compositions therefor, are provided for substantially preventing or reducing the symptoms of at least one infectious disease and at least one chronic immune mediated disorder. An immunogenic challenge which supplements the normal childhood immunization schedule can help ensure the proper maturation of the immune system and prevent the development of chronic immune mediated disorders, such as immune-mediated diabetes or SLE.
REFERENCES:
patent: 4152415 (1979-05-01), Harris
patent: 4625015 (1986-11-01), Green
patent: 4695459 (1987-09-01), Steinman et al.
patent: 4710380 (1987-12-01), Gottlieb
patent: 4857318 (1989-08-01), Lee
patent: 4894332 (1990-01-01), Schaller et al.
patent: 5139776 (1992-08-01), Chazono et al.
patent: 5151023 (1992-09-01), Kuzuhara
patent: 5254340 (1993-10-01), Van Leengoed
patent: 5723283 (1998-03-01), Classen
patent: 5728385 (1998-03-01), Classen
patent: 6420139 (2002-07-01), Classen
patent: 6638739 (2003-10-01), Classen
patent: 0094575 (1983-11-01), None
patent: 0343480 (1989-05-01), None
patent: 8912455 (1989-12-01), None
patent: 9010449 (1990-09-01), None
patent: 9200755 (1992-01-01), None
patent: 9203733 (1992-03-01), None
Dengrove et al. Pediatric Research 20(8): 725-739, 1986.
Madore et al. Pediatrics 85(3): 331-337, 1990.
Hayes. Science 260: 1279-1286, 1993.
Zuckerman et al. J. Hepatol. 22(Suppl. 1): 97-100, 1995.
Spigland et al. Pediatrics , 812-821, 1960.
Adorini et al. Trends in Immunololgy 18(5): 209-211, 1997.
Miller et al. The Biological and Clinical Basis of Infectious Diseases, Chapter 3, pp. 15-28, 1997.
John Brit. Med. Journal. 289:881-882, 1984.
Halsey et al. Bulletin of the World Health Organization 63(6): 1151-1169, 1985.
Ferreri et al., Curr. Ther. Res. 52(3) 1992 (abstract p. 493-497.
Ferreri et al. J. Mol. Info H, Parass H. 113(2) (1990) 150-151 (abstract).
Pediatric Infectious Diseases Journal, 18(3):217-22, 1999.
Boumpas et al., Annals of Internal Medicine, 123(1):42-53, Jul. 1995.
Benveniste, pp. 346-364, and Lagrange et al., pp. 465-502, in Immunology, Bach et al., ed., John Wiley & Sons, New York, 1982.
Webster's II New Riverside Dictionary, Houghton Mifflin Company, Boston, p. 1116, 1994.
Aharon-Maor, et al.,The Good, the Bad and the Ugly of Vaccination, IMAJ, vol. 2, pp. 225-227, Mar. 2000.
Aho, et al.,Rheumatoid Factor and Immuno-Conglutinin Responses Following Various Vaccinations, P.S.E.B.M., vol. 124, pp. 229-233, 1967.
Alm, et al.,Early BCG vaccination and development of atopy, The Lancet, vol. 350, pp. 400-403, Aug. 9, 1997.
Arnqvist, et al.,Difficulties in Classifying Diabetes at Presentation in the Young Adult, Diabetic Medicine, vol. 10, pp. 606-613, Jan. 1993.
Ayvazian, et al.,Disseminated Lupus Erythematosus Occurring Among Student Nurses, The New England Journal of Medicine, vol. 239, No. 16, pp. 565-570, Oct. 14, 1948.
Bamford, et al.,Swine Influenza Vaccination in Patients with Multiple Sclerosis, Arch. Neurol., vol. 35, pp. 242-243, Apr. 1978.
Bijkerk, H.,Mass Vaccination in the Netherlands, International Symposium on Vaccination Against Communicable Diseases, Monaco, vol. 22, pp. 271-276, 1973.
Booy, et al.,Efficacy of Haemophilus Influenzae Type b conjugate vaccine PRP-T, LANCET, vol. 344, Abstract, Aug. 6, 1994.
Brewster, D.,The epidemiology of Haemophilus influenzae invasive disease in Scotland prior to immunisation, Health Bull (EDINB), vol. 51(6), Abstract, Nov. 1993.
Brodman, et al.,Influenzal Vaccine Response in Systemic Lupus Erythematosus, Annals of Internal Medicine, vol. 88, pp. 735-740, 1978.
Bruno, et al.,Comparison of Incidence of Insulin-dependent Diabetes Mellitus in Children and Young Adults in the Province of Turin, Italy, 1984-91, Diabetic Medicine, vol. 14, pp. 964-969, 1997.
Caspary, et al.,Antibody studies in multiple sclerosis and experimental ‘allergic’ encephalomyelitis, J. Neurol. Neurosurg. Psychiat., vol. 27, pp. 25-28, 1964.
Chaleomchan, et al.,Anticardiolipin antibodies in patients with rabies vaccination induced neurological complications and other neurological diseases, Journal of the Neurological Sciences, vol. 96, pp. 143-151, 1990.
Chen, et al.,Vaccine Safety, Lancet, vol. 352, Abstract, 1998.
Chen, et al.,Vaccine Safety Datalink Project: A New Tool for Improving Vaccine Safety Monitoring in the United States, PEDIATRICS, vol. 99, No. 6, pp. 765-773, Jun. 6, 1997.
Classen, John Barthelow,Data links vaccines to risk of Insulin Dependent Diabetes(IDDM), Drug Safety, vol. 21, Abstract, 1999.
Classen, John Barthelow,Diabetes Epidemic Follows Hepatitis B Immunization Program, New Zealand Medical Journal, vol. 190, Abstract, May 24, 1996.
Croke, et al.,Occurrence of Severe Destructive Lyme Arthritis in Hamsters Vaccinated with Outer Surface Protein A and Challenged with Borrelia burgdorferi, Infection and Immunity, vol. 68, No. 2, pp. 658-663, Feb. 2000.
D'Amelio, et al.,Comparative Analysis of Immunological Responses to Oral(Ty21a)and Parenteral(TAB)Typhoid Vaccines, Infection and Immunity, vol. 56, No. 10, pp. 2731-2735, Oct. 1988.
Del Giudice, et al.,Priming to Heat Shock Proteins in Infants Vaccinated against Pertussis, The Journal of Immunology, vol. 150, No. 5, pp. 2025-2032, Mar. 1, 1993.
DeStefano, et al.,Timing of Hepatitis B Vaccination and Risk of Insulin-Dependent Diabetes Mellitus, Pharmacoepidemiology and Drug Safety, vol. 6, suppl. 2, Abstract, 1997.
Hibbs, et al,Internet Web Page Perceptions of Vaccine Pharmacoepidemiology Research: An Analysis of Vaccine Safety Concerns, Pharmacoepidemiology and Drug Safety, vol. 6, suppl. 2, Abstract, 1997.
Dokheel, Tomadher M.,An Epidemic of Childhood Diabetes in the United States?, Diabetes Care, vol. 16, No. 12, pp. 1606-1611, Dec. 1993.
Drykoningen, et al.,The incidence of male childhood type 1(insulin-dependent)diabetes mellitus is rising rapidly in The Netherlands, DIABETOLOGIA, vol. 35, pp. 139-142, 1992.
Eskola, et al.,A Randomized, Prospective Field Trial of a Conjugate Vaccine in the Protection of Infants and Young Children Against Invasive Haemophilus Influenzae Type b Disease, The New England Journal of Medicine, vol. 323, No. 20, pp. 1381-1387, Nov. 15, 1990.
Espmark, et al.,Smallpox Vaccination Before the Age of Three Months: Evaluation of Safety, International Symposium on Smallpox Vaccine, Bilthoven, vol. 19, pp. 243-247, 1972.
Eurodiab Ace Study Group,Variation and trends in Incidence of childhood diabetes in Europe, The Lancet, vol. 355, pp. 873-876, Mar. 11, 2000.
Eurodiab Substudy 2 Study Group,Infections and vaccinations as risk factors for childhood Type 1(insulin-dependent)diabetes mellitus: a multicentre case-control investigation, Diabetologia, vol. 43, pp. 47-53, 2000.
Gardner, et al.,Rising incidence of insulin dependent diabetes in children aged under 5 years in Oxford region: time trend analysis, BMJ, vol. 315, pp. 713-717, Sep. 1997.
Goday, et al.,Incidence of Type 1(insulin-dependent)diabetes mellitus in Catalonia, Spain, DIABETOLOGIA, vol. 35, pp. 267-271, 1992.
Gorham, et al.,Incidence of Insulin-dependent Diabetes Mellitus in Young Adults: Experience of 1,587,630 US Navy Enlisted Personnel, American Journal of Epidemiology, vol. 138, No. 11, pp. 984-987, 1993.
Graves, et al.,Lack of Association Between Early Childhood Immunizations and β-Cell Autoimmunity, Diabetes Care, vol. 22, No. 10, pp. 1694-1697, Oct. 1999.
Griffith, A.H.,Achievements in Europe, International Symposium on Vaccination Against Communicable Diseases, Monaco, vol. 22, pp. 13-24, 1973.
Hackett, et al.,Transient Appearance of “Autoimmune” Antibodies During Prophylactic Immunization, J. Immunology, vol. 85, pp. 533-538, 1960.
Heijbel, et al.,Cumulative Incidence of Childhood-Onset IDDM is Unaffected by Pertussis Immunization, Diabetes Care, vol. 20, No. 2, pp. 173-175, Feb. 1997.
Hemachudha, et al.,Myelin Basic Protein as an Encephalitogen in Encephalomyelitis and Polyneuritis Following Rabies Vaccination, The New England Journal of Medicine, vol. 316, No. 7, pp. 369-374, Feb. 12, 1987.
Herron, et al.,Influenza Vaccination in Patients with Rheumatic Diseases, JAM
Classen Immunotherapies, Inc.
Cooper Iver P.
Park Hankyel T.
LandOfFree
Method and composition for an early vaccine to protect... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for an early vaccine to protect..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for an early vaccine to protect... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3603607